A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia

Fishbane S. et al
JASN September 2019, 30 (9) 1723-1733
Google Plus
LinkedIn
ukidneyisup